SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001171843-17-005488
Filing Date
2017-09-11
Accepted
2017-09-11 16:02:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 f424b5_091117.htm 424B5 588304
2 GRAPHIC logo.jpg GRAPHIC 3856
3 GRAPHIC logo2.jpg GRAPHIC 2986
  Complete submission text file 0001171843-17-005488.txt   599001
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-202466 | Film No.: 171079043
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1